The discursive and political backing from influential sectors in the United States for far-right forces in Germany forms part of a broader process of ...

In the algorithm-mediated ecosystem, comment spaces have become arenas for discursive reinterpretation and confrontation. This study analyzes how journalistic discourse is reconfigured in these ...

The Nike Structure Plus is a stability shoe done right. ZoomX adds softness while ReactX keeps things controlled, and the support feels subtle rather than restrictive. It’s comfortable, versatile and ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the ...

ABSTRACT: With the acceleration of economic globalization and trade liberalization, illegal logging and timber trade, which are closely related to the ecological environment and climate change, have ...

The Bermuda Triangle may not be the biggest mystery of the Atlantic. In a new study published in the journal Geophysical Research Letters, scientists believe they have discovered the reason why ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Anchor your business to a stubborn, real-world problem customers cannot ignore. Replace hustle with systems that standardize decisions, data flow and accountability. Ambition isn’t what holds ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...

Much has been said about dialogism since its creation by the Russian Mikhail Bakhtin. Regardless of whether the philosopher or his circle of students and collaborators was the author of this concept, ...